Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Sales/Fixed Asset

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Sales/Fixed Asset(x) 2.252.382.813.50

What is the latest Sales/Fixed Asset ratio of CORONA REMEDIES ?

The latest Sales/Fixed Asset ratio of CORONA REMEDIES is 2.25 based on Mar2026 Consolidated results.
Year Sales/Fixed Asset
Mar20262.25
Mar20252.38
Mar20242.81
Mar20233.50

How is Sales/Fixed Asset of CORONA REMEDIES Trending?

Years Sales/Fixed Asset % Change
Mar2026 2.25
-5.46
Mar2025 2.38
-15.30
Mar2024 2.81
-19.71
Mar2023 3.5 -

Other Financial Ratios of CORONA REMEDIES


Compare Sales/Fixed Asset ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,551.5 Cr -0.4% 2.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,196.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,967.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,888.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 4.5% 1.8% -10% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.4%

2.3%

NA
SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses